Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bessette

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
The American Journal of Cardiology|September 27, 2023
Utilization of P2Y<sub>12</sub> Inhibitors in Older Adults With ST-Elevation Myocardial Infarction and FrailtyDarae Ko, Ashvin Pande, Kueiyu Joshua Lin, et al.
JAMA Network Open|November 18, 2022
Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020Darae Ko, Kueiyu Joshua Lin, Lily G Bessette, et al.
BMJ (Clinical Research Ed.)|January 13, 2021
STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studiesShirley V Wang, Simone Pinheiro, Wei Hua, et al.
JAMA Network Open|October 27, 2021
Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 DiabetesMin Zhuo, Chelsea E Hawley, Julie M Paik, et al.
Journal of Medical Internet Research|February 13, 2024
Identifying Functional Status Impairment in People Living With Dementia Through Natural Language Processing of Clinical Documents: Cross-Sectional StudyJohn Laurentiev, Dae Hyun Kim, Mufaddal Mahesri, et al.
American Heart Journal|September 23, 2022
Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical careRishi J Desai, Robert J Glynn, Brendan M Everett, et al.
Endocrinology, Diabetes & Metabolism|January 11, 2020
The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical careElisabetta Patorno, Mehdi Najafzadeh, Ajinkya Pawar, et al.
Diabetes Care|January 26, 2021
Comparative Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older AdultsElisabetta Patorno, Ajinkya Pawar, Lily G Bessette, et al.
Computers in Biology and Medicine|February 18, 2025
Comparative ranking of marginal confounding impact of natural language processing-derived versus structured features in pharmacoepidemiologyJoseph M Plasek, Richard D Wyss, Janick G Weberpals, et al.
Annals of Internal Medicine|September 27, 2021
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular DiseaseElisabetta Patorno, Phyo T Htoo, Robert J Glynn, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|September 27, 2023
Utilization of P2Y<sub>12</sub> Inhibitors in Older Adults With ST-Elevation Myocardial Infarction and FrailtyDarae Ko, Ashvin Pande, Kueiyu Joshua Lin, et al.
JAMA Network Open|November 18, 2022
Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020Darae Ko, Kueiyu Joshua Lin, Lily G Bessette, et al.
BMJ (Clinical Research Ed.)|January 13, 2021
STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studiesShirley V Wang, Simone Pinheiro, Wei Hua, et al.
JAMA Network Open|October 27, 2021
Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 DiabetesMin Zhuo, Chelsea E Hawley, Julie M Paik, et al.
Journal of Medical Internet Research|February 13, 2024
Identifying Functional Status Impairment in People Living With Dementia Through Natural Language Processing of Clinical Documents: Cross-Sectional StudyJohn Laurentiev, Dae Hyun Kim, Mufaddal Mahesri, et al.
American Heart Journal|September 23, 2022
Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical careRishi J Desai, Robert J Glynn, Brendan M Everett, et al.
Endocrinology, Diabetes & Metabolism|January 11, 2020
The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical careElisabetta Patorno, Mehdi Najafzadeh, Ajinkya Pawar, et al.
Diabetes Care|January 26, 2021
Comparative Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older AdultsElisabetta Patorno, Ajinkya Pawar, Lily G Bessette, et al.
Computers in Biology and Medicine|February 18, 2025
Comparative ranking of marginal confounding impact of natural language processing-derived versus structured features in pharmacoepidemiologyJoseph M Plasek, Richard D Wyss, Janick G Weberpals, et al.
Annals of Internal Medicine|September 27, 2021
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular DiseaseElisabetta Patorno, Phyo T Htoo, Robert J Glynn, et al.
Pageof 5